Ole Thorlacius-Ussing

Ole Thorlacius-Ussing is a Clinical Professor and Senior Physician at Aalborg University Hospital, affiliated with the Faculty of Health Sciences and the Department of Gastrointestinal Surgery at Aalborg University. His extensive publication record spanning from 1985 to 2025 includes over 286 publications, demonstrating a long and productive academic career focused on gastrointestinal surgery and oncology.

His primary research interests include:

• Colorectal Cancer
• Pancreatic Cancer
• Surgical Oncology
• Gastrointestinal Surgery
• Electroporation Therapy
• Venous Thromboembolism

Professor Thorlacius-Ussing's recent work demonstrates a strong focus on innovative cancer treatments, particularly in pancreatic and colorectal cancer. His research spans fecal microbiota transplantation for chronic pouchitis, gastrointestinal transit time assessment in acute pancreatitis, post-colonoscopy colorectal cancer analysis, biomarker development for pancreatic cancer, and circulating tumor DNA analysis for guiding adjuvant treatment. This reflects a multidisciplinary approach combining surgical expertise with molecular diagnostics and innovative therapeutic techniques.

His notable scientific recognition includes the Robert B. Hunt Award. Professor Thorlacius-Ussing has supervised 9 PhD students throughout his career, contributing significantly to the education and development of the next generation of medical researchers and clinicians.

He is actively involved in several major research projects, particularly focused on pancreatic cancer treatments using electroporation techniques, including the CHEMOFIRE-2 project (Chemotherapy followed by irreversible electroporation in patients with unresectable locally advanced pancreatic cancer) and the EPIC-1 study (A phase II Study of Electroporation Potentiated Immunotherapy in Liver Metastatic Pancreatic Cancer).